Desmoprin Nasal Spray contains Desmopressin 0.1 mg/ml, a synthetic antidiuretic hormone analogue used for management of diabetes insipidus, nocturnal enuresis, and excessive urination disorders.
Desmopressin works by reducing urine production and improving water reabsorption, helping maintain normal fluid balance and preventing dehydration. Its nasal delivery ensures rapid absorption and effective therapeutic response.
Clinically, Desmoprin Nasal Spray is prescribed in endocrinology, pediatric, and urology practice, offering reliable symptom control and good patient compliance.
From a business perspective, Desmoprin Nasal Spray strengthens the hormonal and specialty therapy segment, delivering consistent prescription demand, repeat sales, and strong PCD pharma franchise potential at a best price for franchise partners.
Common side effects may include nasal irritation, headache, nausea, or mild abdominal discomfort. Rare but serious effects may include water retention, hyponatremia, or fluid overload, especially with excessive fluid intake.
Desmoprin Nasal Spray is indicated for the management of central diabetes insipidus, primary nocturnal enuresis (bedwetting), and nocturia associated with reduced antidiuretic hormone secretion. It helps in controlling excessive urination and maintaining fluid balance.
Use Desmoprin Nasal Spray strictly as prescribed by a physician. Fluid intake should be carefully regulated during treatment to avoid water intoxication. Caution is advised in patients with electrolyte imbalance, renal disorders, or cardiovascular conditions. Regular monitoring of serum sodium levels may be required during prolonged use.
Store below 25°C in a cool, dry place. Protect from light and moisture. Keep the bottle tightly closed and out of reach of children. Do not use after the expiry date.